A closer look at the technologies used by PsyRx
See more technologies
PsyRx
Manufacturing · Israel · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Tel Aviv, IsraelPhone Number
+972 522988480Website
www.psyrx.coRevenue
<$5 MillionIndustry
About PsyRx
The world urgently needs a new way to treat mental health conditions, and at Psyrx we are developing a combination of an approved drug from the SSRI family with a low dosage of ibogaine. Meant to improve antidepressant treatment, with a convenient daily dose - the treatment does not cause a psychedelic effect and is non-disruptive to people’s way of life. It also decreases the side effects of current medications – aimed at transforming and optimizing mental health treatment outcomes. At Psyrx we believe psychedelics are a big part of the solution for the global mental health crisis. Bringing over 20 years of experience in the pharmaceutical, medical device and cannabis industries, we set out to transform the growing psychedelic drug discovery market. Psyrx is one of the few companies to offer GMP-approved, API of Psilocybin and Ibogaine.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
PsyRx Tech Stack
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PsyRx
Sign Up For FreeTo access detailed company insights
The world urgently needs a new way to treat mental health conditions, and at Psyrx we are developing a combination of an approved drug from the SSRI family with a low dosage of ibogaine. Meant to improve antidepressant treatment, with a convenient daily dose - the treatment does not cause a psychedelic effect and is non-disruptive to people’s way o... Read More
